Blocking CXCR3 with NBI-74330 in tumor-bearing wildtype and Cxcr3ko mice prolonged the median survival of both groups but had no impact on tumor-infiltrating microglia and lymphocytes [169]. This evidence concerns the gene CXCR3 and neoplasm.